BACK · As filed with the SEC
IMAC Holdings cash flow statement, by quarter
The statement as IMAC Holdings presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.
Condensed Consolidated Statements of Cash Flows (Unaudited) · USD
| USD | Q3 2025† 3 months ended Sep 30, 2025 | Q2 2025† 3 months ended Jun 30, 2025 | Q1 2025 3 months ended Mar 31, 2025 | Q4 2024† 3 months ended Dec 31, 2024 | Q3 2024† 3 months ended Sep 30, 2024 | Q2 2024† 3 months ended Jun 30, 2024 | Q1 2024 3 months ended Mar 31, 2024 | Q4 2023† 3 months ended Dec 31, 2023 |
|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||
| Net loss | — | — | (2,199,868) | (5,050,556)† | — | — | — | (1,458,156)† |
| Net loss from discontinuing operations | — | — | — | (2,716,057)† | (103,374)† | — | — | (746,822)† |
| Profit or Loss | — | — | — | (2,334,499)† | (2,101,274)† | — | — | (711,334)† |
| Net Income | (3,078,533)† | — | — | — | (2,204,648)† | (1,383,404)† | (407,219) | — |
| Income from Discontinued Operations | (10,374)† | 0† | 314 | — | (103,374)† | 29,702† | — | — |
| Income from Continuing Operations | (3,068,159)† | (2,120,265)† | (2,200,182) | — | (2,101,274)† | (1,413,106)† | — | — |
| Adjustments to reconcile net loss to net cash used in operating activities: | ||||||||
| Depreciation Expense | 52,193† | 52,193† | 52,193 | 52,194† | 52,193† | — | — | 16,746† |
| Interest Expense | 465,928† | 148,153† | 11,465 | 518,920† | 106,636† | — | — | — |
| Provision for Doubtful Accounts (CF) | — | — | — | — | — | — | (45,472) | 370,072† |
| Stock-Based Compensation Expense | — | — | — | 31,853† | — | — | — | (7,538)† |
| Loss on disposition of assets | — | — | — | — | — | — | — | (2,167,510)† |
| Changes in operating assets and liabilities: | ||||||||
| Accounts receivable | 0† | 0† | 28,030 | 13,670† | (25,950)† | (61,222)† | 45,472 | 366,198† |
| Other assets | — | — | — | — | — | — | 28,535 | 268,325† |
| Prepaid expenses and other current assets | (30,570)† | (37,668)† | (44,641) | 148,944† | (60,511)† | (83,608)† | — | 268,325† |
| Net Cash from Operating Activities | — | — | — | — | — | — | — | 55,452† |
| Right of use/lease liability | — | — | — | — | — | — | — | (114,756)† |
| Accounts payable and accrued expenses | 409,144† | 662,445† | 1,119,512 | 3,148,112† | 1,033,619† | 705,647† | 176,432 | (327,856)† |
| Patient deposits | — | — | — | — | — | — | — | (125,214)† |
| Net cash used in operating activities from continuing operations | (1,423,363)† | (1,295,142)† | (1,033,623) | 1,579,194† | (991,725)† | (757,578)† | — | 913,827† |
| Net Cash from Operating Activities | (10,374)† | 0† | 314 | (2,716,057)† | (103,374)† | 29,702† | — | (746,823)† |
| Net cash used in operating activities | (1,433,737)† | (1,295,142)† | (1,033,309) | (1,136,863)† | (1,095,099)† | (727,876)† | (202,252) | 167,005† |
| Cash flows from investing activities: | ||||||||
| Note receivable | — | — | — | 0† | 0† | — | — | 0† |
| Proceeds from Sale of PP&E | — | — | — | — | — | — | — | (50,000)† |
| Net cash used in investing activities | — | — | — | 0† | 0† | — | — | 94,700† |
| Cash flows from financing activities: | ||||||||
| Stock Repurchases (Issuances) | 0† | 0† | 100,000 | — | — | — | — | (47,382)† |
| Proceeds from Stock Issuance | — | — | — | 1,245,541† | 0† | — | — | (255,000)† |
| Payments on notes payable | — | — | — | — | — | — | — | 50,249† |
| Proceeds from Debt Issuance | 1,436,126† | 1,306,927† | 460,000 | 200,000† | 400,000† | — | — | — |
| Payments on finance lease obligation | — | — | — | 0† | 0† | 0† | (1,724) | (12,707)† |
| Net cash provided in financing activities | 1,436,126† | 1,306,927† | 560,000 | 1,445,541† | 400,000† | 1,975,951† | (1,724) | (264,840)† |
| Net decrease in cash | 2,389† | 11,785† | (473,309) | 308,678† | (695,099)† | 873,075† | (203,976) | (3,135)† |
| Cash, beginning of period | 42,665 | 30,880 | 504,189 | 195,511 | 890,610 | 17,535 | 221,511 | 224,646 |
| Cash, end of period | 45,054 | 42,665 | 30,880 | 504,189 | 195,511 | 890,610 | 17,535 | 221,511 |
| Supplemental cash flow information: | ||||||||
| Interest Expense | — | — | — | — | — | — | 40,583 | 33,325† |
| Preferred stock conversion | 0† | 0† | 4 | 0† | — | — | — | — |
| Accrued dividends | — | — | — | 90,000† | 304,000† | 777,635† | 79,365 | 75,000† |
| Converted accrued C1 & C2 dividends | — | — | 178,000 | — | — | — | — | — |
| Preferred dividends accrued – C-1 & C-2 | — | 73,000† | 72,000 | — | — | — | — | — |
| Preferred dividends accrued – B-1 | — | — | — | — | 0† | 9,000† | — | — |
| Preferred dividends accrued converted into C-1 & C-2 | (356,000)† | — | — | — | (436,000)† | — | — | — |
| Capitalized dividends – D, E F & G | — | 1,170,000† | 1,142,000 | — | — | — | — | — |
| Settlement of notes receivable in connection with asset purchase agreement | — | — | — | (39,000)† | 0† | — | — | — |
† Derived: worked out from the filings, not stated in them. A fourth quarter is the 10-K year less the nine months in the third-quarter 10-Q; a quarter of cash flows is year to date less the prior year to date.
As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.
Data on this page was fetched . The filing on SEC.gov is the record.